Literature DB >> 22418733

Genetic analysis of LRRK2 A419V variant in ethnic Chinese.

Nan-Nan Li1, Eng-King Tan, Xue-Li Chang, Xue-Ye Mao, Jin-Hong Zhang, Dong-Mei Zhao, Qiao Liao, Rong Peng.   

Abstract

Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are the most common causes of autosomal dominant and sporadic forms of Parkinson's disease (PD). The A419V variant has been suggested to be a potential risk variant but its role among Chinese is unclear. We genotyped LRRK2 A419V variant to investigate the association with risk of PD. A total of 1314 subjects comprising 729 patients with PD and 585 controls were genotyped. Twenty-two (3.0%) patients were heterozygous carriers for the A419V variant, and the frequency was higher compared with controls (0.7%, p = 0.003). The association was seen among the younger age group (early onset PD patients vs. controls: p = 0.0005), but was not significant among the older age group (late onset PD patients vs. controls: p = 0.17). We showed a significant association of LRRK2 A419V variant among early onset PD in the ethnic Han Chinese population but not among late onset PD. Further replication studies in additional Chinese and other Asian cohorts will be important to address its potential pathophysiologic role.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22418733     DOI: 10.1016/j.neurobiolaging.2012.02.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  3 in total

1.  Identification of Targets from LRRK2 Rescue Phenotypes.

Authors:  Joanne Toh; Ling Ling Chua; Patrick Ho; Edwin Sandanaraj; Carol Tang; Hongyan Wang; Eng King Tan
Journal:  Cells       Date:  2021-01-05       Impact factor: 6.600

Review 2.  LRRK2: cause, risk, and mechanism.

Authors:  Coro Paisán-Ruiz; Patrick A Lewis; Andrew B Singleton
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

3.  LRRK2 Mutations and Asian Disease-Associated Variants in the First Parkinson's Disease Cohort from Kazakhstan.

Authors:  Rauan Kaiyrzhanov; Akbota Aitkulova; Chingiz Shashkin; Nazira Zharkinbekova; Mie Rizig; Elena Zholdybayeva; Zharkyn Jarmukhanov; Vadim Akhmetzhanov; Gulnaz Kaishibayeva; Talgat Khaibullin; Altynay Karimova; Serik Akshulakov; Askhat Bralov; Nurlan Kissamedenov; Zhanar Seidinova; Anjela Taskinbayeva; Aliya Muratbaikyzy; Henry Houlden
Journal:  Parkinsons Dis       Date:  2020-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.